BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32316074)

  • 1. The effect of an intervention program on the knowledge and attitudes among medical staff regarding adverse drug reaction reporting.
    Shchory MP; Goldstein LH; Arcavi L; Shihmanter R; Berkovitch M; Levy A
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1246-1253. PubMed ID: 32316074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing adverse drug reaction reporting-How can we do better?
    Potlog Shchory M; Goldstein LH; Arcavi L; Shihmanter R; Berkovitch M; Levy A
    PLoS One; 2020; 15(8):e0235591. PubMed ID: 32790671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital.
    Ergün Y; Ergün TB; Toker E; Ünal E; Akben M
    Int Health; 2019 May; 11(3):177-184. PubMed ID: 30265317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reaction reporting by nurses in Sweden.
    Bäckström M; Ekman E; Mjörndal T
    Eur J Clin Pharmacol; 2007 Jun; 63(6):613-8. PubMed ID: 17404719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.
    Ekman E; Bäckström M
    Eur J Clin Pharmacol; 2009 Jan; 65(1):43-6. PubMed ID: 18825377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
    Lee KK; Chan TY; Raymond K; Critchley JA
    Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
    Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
    BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.
    Oshikoya KA; Awobusuyi JO
    BMC Clin Pharmacol; 2009 Aug; 9():14. PubMed ID: 19671176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
    Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
    Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.
    Shrestha S; Sharma S; Bhasima R; Kunwor P; Adhikari B; Sapkota B
    BMC Med Educ; 2020 Jun; 20(1):179. PubMed ID: 32493307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions reporting practice and associated factors among community health extension workers in public health facilities, Southwest, Nigeria.
    Adedeji WA; Adegoke AB; Fehintola FA
    Pan Afr Med J; 2021; 40():165. PubMed ID: 34970407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.